Generalized seborrhoeic dermatitis. Clinical and therapeutic data of 25 patients

Insights

This study found intravenous biotin effective for infant seborrhoeic dermatitis, with rapid skin lesion improvement. Antibiotics are recommended for bacterial infections alongside biotin treatment.

Area of Science:

  • Pediatrics
  • Dermatology
  • Nutritional Science

Background:

  • Generalized seborrhoeic dermatitis is common in infants.
  • Optimum treatment protocols require further investigation.

Purpose of the Study:

  • To evaluate the efficacy of biotin and vitamin B complex in treating infant seborrhoeic dermatitis.
  • To establish optimal administration routes and antibiotic use in conjunction with biotin therapy.

Main Methods:

  • Twenty-five infants with generalized seborrhoeic dermatitis were studied.
  • Treatment groups received varying intravenous biotin dosages and durations, with one group receiving vitamin B complex plus biotin.
  • Antibiotics were administered based on clinical findings, leucocyte counts, and differential white blood cell counts.

Main Results:

  • All treatment groups showed excellent results, with skin lesions improving in 4–8 days and clearing in 15–30 days.
  • Intravenous biotin administration was found to be less painful and dangerous than intramuscular injections.
  • Leucocyte counts and chest X-rays were recommended for all cases.

Conclusions:

  • Intravenous biotin is a safe and effective treatment for infant seborrhoeic dermatitis.
  • Combined biotin and antibiotic therapy is recommended for cases with bacterial infection.
  • Further research into optimal biotin dosages and administration schedules is warranted.